Double standards seem to prevail for generic drugsBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7333.365 (Published 09 February 2002) Cite this as: BMJ 2002;324:365
- Graham Howarth, associate professor (email@example.com)
- University of Pretoria, Suite 21, P/Bag X 87, Bryanston 2021, South Africa
EDITOR—The World Trade Organisation tightened legislation on intellectual property by passing the trade related intellectual property rights (TRIPS) agreement in 1995. This was largely facilitated by developed countries. The agreement placed restrictions on manufacturing generic drugs and parallel …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial